Cambria prison officials catch inmate medication billing mistakes
EBENSBURG, Pa. – Cambria County Prison officials discovered that county taxpayers have been mistakenly billed in excess by the prison's contracted medical care provider for some inmate opioid addiction medications.
Assistant Deputy Warden Megan Bursky reviewed invoices from the prison's contracted medical service provider, PrimeCare Medical, and found the prison had been overbilled for methadone treatment by roughly $10,000 since February.
Bursky gave a report Wednesday to the county's prison board at the Cambria County Courthouse.
She said the prison had changed its contract with PrimeCare to achieve savings through having prison personnel pick up the methadone treatments rather than having them delivered.
However, due to a communication lapse between new and former PrimeCare administrators, she said, the methadone price was not dropped to reflect the new contract.
In addition, she found that, since October, the prison has been double billed for inmates' Subutex medications.
That medication should have been billed only to the prison's Medical Assisted Treatment program account, which is funded with monies from national opioid settlements.
However, the same Subutex charges were included in bills for the prison's general medications, she said.
The amount billed in excess for Subutex has not been tallied, but Bursky estimates it to be 'significant.'
Bursky said she brought the issues to PrimeCare, which recognized the mistakes and is correcting the problem. She attributed the mistakes to a communication lapse resulting from administrative turnover at PrimeCare.
A call to PrimeCare was not returned Wednesday.
Cambria County Prison Board member and county Controller Ed Cernic said the prison has experienced similar billing issues with PrimeCare over the past few years.
The prison pays more than $3 million a year for inmate medications and services, he said.
The prison board has looked for other medical service providers in the past, but there are not many providers aside from PrimeCare, Cernic said.
Cambria County Prison Warden Kurt Wolford said his administration is looking to improve cost efficiency of programs throughout the prison and improve every facet of the facility.
'We are moving in a direction that is more fiscally responsible to the county – and safer – not only for officers but inmates as well,' he said.
A major focus since Wolford's entry to the warden's office in April has been the development of a re-entry program for inmates to society. The planned program, including the future hire of a re-entry specialist at the prison, is funded by a state grant obtained in partnership with other county departments.
The role of a re-entry specialist would include addressing substance abuse disorders, as well as connecting inmates to medical services and housing in advance of their release from prison so that their transition back to society is smoother.
'There are two ways to look at the prison from the public perspective,' Wolford said. 'Half of people think we shouldn't give inmates anything, but others, including myself, see our jobs as a way to help fix problems while people are in here, so when they come out, they are more active citizens. It makes the community safer.'
Russ O'Reilly is a reporter for The Tribune-Democrat. Follow him on Twitter @RussellOReilly.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 days ago
- Yahoo
Cambria prison officials catch inmate medication billing mistakes
EBENSBURG, Pa. – Cambria County Prison officials discovered that county taxpayers have been mistakenly billed in excess by the prison's contracted medical care provider for some inmate opioid addiction medications. Assistant Deputy Warden Megan Bursky reviewed invoices from the prison's contracted medical service provider, PrimeCare Medical, and found the prison had been overbilled for methadone treatment by roughly $10,000 since February. Bursky gave a report Wednesday to the county's prison board at the Cambria County Courthouse. She said the prison had changed its contract with PrimeCare to achieve savings through having prison personnel pick up the methadone treatments rather than having them delivered. However, due to a communication lapse between new and former PrimeCare administrators, she said, the methadone price was not dropped to reflect the new contract. In addition, she found that, since October, the prison has been double billed for inmates' Subutex medications. That medication should have been billed only to the prison's Medical Assisted Treatment program account, which is funded with monies from national opioid settlements. However, the same Subutex charges were included in bills for the prison's general medications, she said. The amount billed in excess for Subutex has not been tallied, but Bursky estimates it to be 'significant.' Bursky said she brought the issues to PrimeCare, which recognized the mistakes and is correcting the problem. She attributed the mistakes to a communication lapse resulting from administrative turnover at PrimeCare. A call to PrimeCare was not returned Wednesday. Cambria County Prison Board member and county Controller Ed Cernic said the prison has experienced similar billing issues with PrimeCare over the past few years. The prison pays more than $3 million a year for inmate medications and services, he said. The prison board has looked for other medical service providers in the past, but there are not many providers aside from PrimeCare, Cernic said. Cambria County Prison Warden Kurt Wolford said his administration is looking to improve cost efficiency of programs throughout the prison and improve every facet of the facility. 'We are moving in a direction that is more fiscally responsible to the county – and safer – not only for officers but inmates as well,' he said. A major focus since Wolford's entry to the warden's office in April has been the development of a re-entry program for inmates to society. The planned program, including the future hire of a re-entry specialist at the prison, is funded by a state grant obtained in partnership with other county departments. The role of a re-entry specialist would include addressing substance abuse disorders, as well as connecting inmates to medical services and housing in advance of their release from prison so that their transition back to society is smoother. 'There are two ways to look at the prison from the public perspective,' Wolford said. 'Half of people think we shouldn't give inmates anything, but others, including myself, see our jobs as a way to help fix problems while people are in here, so when they come out, they are more active citizens. It makes the community safer.' Russ O'Reilly is a reporter for The Tribune-Democrat. Follow him on Twitter @RussellOReilly.
Time Business News
04-06-2025
- Time Business News
Food Addiction and Emotional Eating: Where Is the Line?
Food consumption is a fundamental biological imperative. Yet, for many, the act of eating transcends nourishment and becomes enmeshed with complex psychological and neurochemical processes. Food addiction and emotional eating are two manifestations of this entanglement. While they share overlapping traits, the boundary between them is often elusive, challenging clinicians and individuals alike. Accessing Treatment in the Digital Age In recent years, telemedicine has transformed how individuals receive care, particularly for those struggling with opioid dependence. One of the most significant developments is the ability to obtain a Subutex prescription online , offering a more private and accessible route for patients seeking help. This method reduces barriers like travel time, stigma, and limited local resources. Licensed healthcare providers can now evaluate patients remotely and, if appropriate, prescribe necessary medications securely. While this innovation enhances convenience, it also underscores the importance of responsible prescribing and ongoing support to ensure safe and effective treatment outcomes. Understanding Food Addiction Food addiction is characterized by compulsive consumption of certain foods, particularly those high in sugar, fat, and salt. Neuroimaging studies reveal that these foods activate the brain's reward circuitry—specifically the mesolimbic dopamine pathway—in a manner akin to drugs of abuse. This neurochemical hijacking precipitates intense cravings and diminished control over intake. Behaviorally, food addiction manifests in binge episodes, unsuccessful attempts to cut down, and continued consumption despite adverse consequences. The presence of additives like refined sugars and emulsifiers may exacerbate this compulsion, altering gut microbiota and signaling pathways that perpetuate cravings. This creates a cycle reminiscent of substance dependency, where tolerance and withdrawal phenomena can emerge. Exploring Emotional Eating Emotional eating, by contrast, is primarily a psychological response to affective states. Stress, loneliness, boredom, and sadness can all trigger a desire to eat for comfort rather than hunger. This behavior functions as a maladaptive coping mechanism, momentarily soothing distress through the hedonic pleasure of food. Unlike food addiction's compulsivity, emotional eating often follows identifiable emotional cues and fluctuates with mood. It may not involve the same intensity of craving or loss of control, but it still contributes to unhealthy patterns when habitual. The cyclical nature of emotional eating reinforces negative emotions, fostering guilt and shame that can further entrench the behavior. Biological and Psychological Overlaps Despite apparent differences, food addiction and emotional eating share substantial biological and psychological commonalities. Both engage neurochemical systems involving dopamine, serotonin, and stress hormones like cortisol. Emotional dysregulation—difficulty modulating emotional responses—acts as a fulcrum on which both phenomena pivot. Mood disorders such as depression and anxiety often coexist with either condition, complicating the clinical picture. For instance, an individual may alternate between compulsive overeating driven by addiction-like neurobiology and episodes of emotional eating triggered by psychological distress. This convergence blurs diagnostic boundaries and demands a holistic understanding. Diagnostic Challenges and Clinical Perspectives Current diagnostic frameworks, such as those outlined in DSM-5, do not formally recognize food addiction as a distinct disorder, which complicates clinical recognition. Emotional eating is similarly under-defined, often considered a symptom rather than a diagnosis. This ambiguity necessitates nuanced assessment tools that evaluate behavioral patterns, emotional context, and neurobiological markers. Effective treatment hinges on correctly identifying the predominant drivers behind disordered eating. For some, pharmacological interventions targeting neurochemical imbalances may be appropriate. For others, psychotherapeutic modalities focusing on emotional regulation and stress management prove more efficacious. The subtleties of overlap require clinicians to tailor interventions meticulously. Strategies for Intervention and Management Behavioral therapies, such as cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT), offer potent strategies to reframe maladaptive thoughts and cultivate healthier coping mechanisms. Mindfulness-based approaches encourage greater awareness of hunger cues and emotional states, disrupting automatic eating responses. Nutritional guidance plays a vital role by promoting balanced diets that minimize highly processed foods known to exacerbate addictive-like behaviors. Modifying the food environment—removing trigger foods and fostering structured meal patterns—can reduce vulnerability. Addressing emotional regulation is paramount, especially where trauma or chronic stress underpins disordered eating. Integrative treatment models that combine psychological support with nutritional education yield the most sustainable outcomes. A Path Toward Recovery with the Right Support Finding effective treatment for opioid addiction can feel overwhelming, but the right approach can make all the difference. One widely used option is Subutex, a medication that helps ease withdrawal symptoms and reduce cravings during the recovery process. If you're searching for Subutex treatment near me , local clinics and outpatient programs can provide professional support tailored to your individual needs. These centers often combine medication-assisted treatment with counseling and behavioral therapy, offering a comprehensive recovery plan. With guidance from trained medical professionals, you can begin to rebuild your life and regain control over your future. Conclusion The distinction between food addiction and emotional eating is often a spectrum rather than a clear divide. Both represent complex interactions between brain chemistry, emotional health, and behavior. Understanding this continuum is crucial to developing compassionate, individualized treatment approaches that recognize the multifaceted nature of disordered eating. Only through this lens can lasting recovery and wellness be achieved. TIME BUSINESS NEWS
Associated Press
04-06-2025
- Associated Press
Global Technologies, LTD Announces Strategic Pivot and New Agreements in Health & Wellness Sector
Greensboro, NC, June 04, 2025 (GLOBE NEWSWIRE) -- Global Technologies, LTD (OTCPK: GTLL), a public, multi-operational company focused on innovation in health and wellness, recently announced corporate developments and commercial milestones signaling a bold pivot in strategy and leadership. Over the past 90 days, GTLL has responded proactively to external FDA regulatory shifts that disrupted several industry sectors, including GLP-1 compounding and semaglutide supply. These changes catalyzed GTLL's sharpened focus on the digital health and wellness market, prompting operational streamlining and a commitment to scalable, revenue-focused platforms—particularly through its newly launched subsidiary, Primecare Supply, LLC. Launch of Primecare Supply and Execution of Key Agreements As disclosed in its May 30, 2025 Form 8-K filing, GTLL formally launched Primecare Supply, LLC and executed two transformative commercial agreements: These agreements position Primecare—and GTLL—at the forefront of compliant pharmaceutical distribution and digital wellness innovation. Leadership Appointments and Strategic Realignment In line with the Company's refined strategy, H. Wyatt Flippen has been officially appointed Chairman of the Board in addition to his role as Chief Executive Officer. Concurrently, GTLL has removed the President of its clean energy subsidiary, GOe3, LLC, to allow for a full transition away from non-core operations in the EV sector. 'We are building a business that's leaner, more focused, and directly aligned with FDA-compliant pharmaceutical distribution and digital wellness innovation,' said Flippen. 'These agreements and leadership changes reflect our resolve to reduce complexity, expand into higher-growth sectors, and deliver long-term shareholder value.' A Clearer Path Ahead GTLL is aggressively expanding its offerings in consumer-facing wellness plans and therapeutic products, leveraging both traditional partnerships and digital infrastructure. The Company is now fully aligned around the growth of its Primecare platform and related ventures, with future announcements anticipated regarding new reseller relationships, patient outreach programs, and proprietary health technologies. About Global Technologies, LTD Global Technologies, LTD (OTCPK: GTLL) is a public, multi-operational company committed to building scalable businesses in digital health, wellness, and technology. Through acquisitions, strategic licensing, and integrated platforms, GTLL delivers innovative solutions to improve lives and expand shareholder value. Forward Looking Statements: Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations or predictions of future events, are forward-looking statements. The words 'believe,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'will' and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results; levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements. No information contained in this press release should be construed as any indication whatsoever of the Company's future financial performance, future revenues or its future stock price. The forward-looking statements contained herein represent the judgment of the Company as of the date of this press release, and the Company expressly disclaims any intent, obligation or undertaking to update or revise such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. No information in this press release should be construed as any indication whatsoever of the Company's future revenues or results of operations. Investor Contact: Wyatt Flippen, CEO and Chairman of the Board [email protected]
